Ignite Creation Date:
2025-12-24 @ 9:14 PM
Ignite Modification Date:
2025-12-30 @ 1:09 AM
Study NCT ID:
NCT04843904
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-07-15
First Post:
2021-03-30
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safe Accelerated Venetoclax Escalation in CLL
Sponsor:
Dana-Farber Cancer Institute
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-04-14
Start Date Type:
ACTUAL
Primary Completion Date:
2025-06-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2030-06-02
Completion Date Type:
ESTIMATED
First Submit Date:
2021-03-30
First Submit QC Date:
None
Study First Post Date:
2021-04-14
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-07-10
Last Update Post Date:
2025-07-15
Last Update Post Date Type:
ACTUAL